ELI LILLY & Co — Director's Dealing 2017

May 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-05-01

Reporting Person: Shaw Christi (SVP and Pres., Lilly Bio-Meds)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-01	Restricted Stock Unit	$	A	27500	Acquired		Common Stock (27500.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019.